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surveillance are needed to understand the association 
between IPA and severe influenza and performance 
of galactomannan testing in patients with severe in-
fluenza. Nonetheless, it is essential for clinicians to 
consider IPA in patients with severe influenza who 
do not improve with treatment, even in those who are 
not immunocompromised.
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West Nile virus (WNV), the causative agent of West Nile fever (WNF), is an arbovirus of the 
genus Flavivirus, family Flaviviridae. WNV has been 
reported in a variety of species but is maintained 
mainly between birds and ornithophilic mosquitoes, 
with incidental transmission to end hosts, such as 
humans, horses, and other vertebrates (1). Recently, 
WNV was detected in snakes (2), and antibodies 
against WNV were found in farmed crocodiles (Cro-
codylus niloticus) in Israel and Mexico and in alliga-
tors (Alligator mississippiensis) in the United States (3). 
Moreover, a severe outbreak of WNV neurologic dis-
ease in farmed alligators was reported in Florida (4). 
Meanwhile, the role of reptiles in the epidemiology of 
WNV remains obscure.
Up to 9 genetic lineages of WNV have been pro-
posed (5), but lineages 1 and 2 have been associated 
with most human outbreaks of neurologic disease. 
Lineage 1 is globally distributed, and major out-
breaks involving this lineage have been reported 
in the Americas, Europe, Asia, Oceania, and North 
Africa (5). In contrast, lineage 2 was reported ex-
clusively in southern Africa and Madagascar until 
the 2000s, when it emerged in Europe (6). Although 
lineage 2 is predominant in southern Africa, WNV 
lineage 1 was detected in a pregnant mare in South 
Africa in 2010 (7).
In March 2019, a crocodile farm in Southern 
Province, Zambia, reported that some yearlings 
had exhibited clinical signs including anorexia, 
weakness, swimming in circles, bloody diarrhea, 
and scoliosis and were euthanized. Postmortem ex-
amination revealed congestion of the lungs, hem-
orrhagic intestines and trachea, and hydropericar-
dium. Clinical signs and postmortem findings led 
to the suspicion of WNF, coccidiosis, salmonello-
sis, or enterotoxemia. We collected 11 whole blood 
samples from the postoccipital sinus of the spinal 
vein of affected crocodiles for molecular detection 
of WNV. 
We used a QIAamp Viral RNA Mini Kit 
(QIAGEN, https://www.qiagen.com) to extract to-
tal RNA and the OneStep RT-PCR Kit (QIAGEN) 
to detect part of the WNV genome by using the 
primer pair WNNY-514 (5′-CGG CGC CTT CAT 
ACA CW-3′) and WNNY-905 (5′-GCC TTT GAA 
CAG ACG CCA TA-3′). These primers amplified 
an ≈400 bp fragment in 2/11 samples tested, which 
we then used for direct Sanger sequencing. The 2 
nucleotide sequences we obtained were 100% iden-
tical to each other, and a BLAST analysis (https://
blast.ncbi.nlm.nih.gov) showed 99% sequence 
identity to WNV isolate ArD76986/1990/SN (Gen-
Bank accession no. KY703854), which was detected 
from Culex poicilipes mosquitoes in Senegal (5). To 
obtain the complete sequence of the polyprotein 
gene, we designed several overlapping primers 
(Appendix Table, https://wwwnc.cdc.gov/EID/
article/26/4/19-0954-App1.pdf) to use in reverse 
transcription PCR (RT-PCR) assays and sequenc-
ing. We deposited the sequence, Croc110/2019/
ZM, in GenBank (accession no. LC489409).
For phylogenetic analysis, we aligned complete 
polyprotein amino acid sequence of Croc110/2019/
ZM and reference sequences from GenBank by us-
ing MUSCLE (http://www.drive5.com/muscle). 
We constructed the phylogenetic tree in MEGA6 
(https://www.megasoftware.net) by using the 
maximum-likelihood method and the Jones-Tay-
lor-Thornton matrix-based model with 1,000 boot-
strap replicates. Phylogenetic analysis revealed that 
Croc110/2019/ZM belonged to lineage 1a (Figure) 
and was most closely related to a WNV isolate from 
a camel in the United Arab Emirates (GenBank acces-
sion no. KU588135) and isolate ArD76986/1990/SN 
from Senegal (accession no. KY703854).
Our study confirmed WNV infection in farmed 
crocodiles in Africa. Clinical signs and pathological 
changes in multiple organs correlated with those de-
scribed for WNV infection in farmed American al-
ligators in the United States (4). The source of the 
WNV in the outbreak remains unresolved. WNV 
might have been circulating on the farm because the 
farmer indicated that lymphohistiocytic proliferative 
cutaneous lesions were observed in the crocodiles 
for some time. Such lesions can be associated with 
WNV infection and cause considerable economic 
losses because of lowered skin quality (8). Transmis-
sion among the crocodiles could occur orally from 
cannibalism and by cloacal shedding of WNV from 
infected animals (8).
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We detected West Nile virus (WNV) nucleic acid in croco-
diles (Crocodylus niloticus) in Zambia. Phylogenetically, 
the virus belonged to lineage 1a, which is predominant 
in the Northern Hemisphere. These data provide evi-
dence that WNV is circulating in crocodiles in Africa and 
increases the risk for animal and human transmission.
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Figure. Phylogenetic tree of complete polyprotein 
amino acid sequences of West Nile virus (WNV) from 
farmed crocodiles, Zambia (black dot), and reference 
sequences. Phylogenetic analysis was conducted 
by using the maximum likelihood method based on 
the JTT matrix-based model with 1,000 bootstrap 
replicates using MEGA6 software (https://www.
megasoftware.net). Bootstrap values >60% are shown 
next to the branches. The analysis involved 52 amino 
acid sequences; there were a total of 3,415 positions 
in the final dataset. All positions containing gaps and 
missing data were eliminated. Reference sequences 
included in the analysis are shown with their GenBank 
accession numbers, strain name or source, and 
country of origin. Black square indicates WNV 
previously detected from mosquito in the Western 
Province of Zambia. Scale bar indicates nucleotide 
substitutions per site.
Phylogenetic analysis of the complete poly-
protein amino acid sequence of Croc110/2019/ZM 
grouped the virus in lineage 1a. Previous mosquito 
surveillance studies in Western Province, Zambia, 
identified WNV lineage 2 from Culex quinquefasciatus 
mosquitoes (9). Our findings suggest that multiple 
WNV lineages are co-circulating in Zambia and that 
multiple host species could be involved.
WNF outbreaks have not been reported in hu-
mans in Zambia, but 10.3% of 3,625 persons who 
participated in a serosurvey were seropositive for 
WNV in Western and North-Western provinces of 
the country (10), suggesting possible WNV infec-
tion. Detection of WNV in mosquitoes in Western 
Province and our finding of the virus in crocodiles 
in Southern Province suggest that WNV could be 
a neglected emerging infectious pathogen and 
might be associated with WNF in animals and 
humans in Zambia. Our study stresses the need 
for increased clinical awareness among veterinary 
and medical practitioners and continued moni-
toring of WNV in vectors and animals, including 
reptiles, to clarify the ecology and life cycle of this 
pathogen, particularly in regions where WNF is 
poorly understood.
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